ClassID:

170819

G01N2800/127 - CPC Classification

Classification description:

Detection or diagnosis of diseases; Pulmonary diseases Bronchitis

Recent Application in this class:
#1
20250035617
2025-01-30

Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression

#2
20240298920
2024-09-12

SYSTEMS AND METHODS FOR MONITORING RESPIRATORY GASES

#3
20230176074
2023-06-08

BIOMARKERS FOR THE DIAGNOSIS OF RESPIRATORY TRACT INFECTIONS

#4
20220205987
2022-06-30

Methods for categorizing and treating subjects having cystic fibrosis (CF) and at risk for severe pulmonary exacerbation

#5
20200256859
2020-08-13

Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression

#6
20200191802
2020-06-18

Methods for diagnosing or predicting chronic bronchitis

#7
20190391145
2019-12-26

ALX receptor ligands define a biochemical endotype for inflammation-based diseases

#8
20190128878
2019-05-02

Methods for categorizing and treating subjects at risk for pulmonary exacerbation and disease progression

#9
20150322520
2015-11-12

Method for treating pulmonary exacerbation and disease progression in subjects having cystic fibrosis

#10
20120039921
2012-02-16

Poultry viral materials and methods related thereto

#11
20120015992
2012-01-19

Naphthalene-based inhibitors of anti-apoptotic proteins

#12
20120004311
2012-01-05

Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)

#13
20110097353
2011-04-28

POULTRY VIRAL MATERIALS AND METHODS RELATED THERETO

#14
20100267781
2010-10-21

Naphthalene-based inhibitors of anti-apoptotic proteins

#15
20090275738
2009-11-05

Use of A33 antigens and JAM-IT

#16
20080312421
2008-12-18

Use of A33 antigens and JAM-it

#17
20070190049
2007-08-16

Use of A33 antigens and JAM-IT

#18
20070031405
2007-02-08

Use of A33 antigens and jam-it

#19
20060233803
2006-10-19

Use of A33 antigens and JAM-it